Artemis Medicare Services Limited (ARTEMISMED) fundamentals
Artemis Medicare Services Limited is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as ARTEMISMED (ISIN INE025R01021). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Artemis Medicare Services Limited does
Artemis Medicare Services Limited is an India-based company. The Company manages and operates a multi-specialty hospital. It specializes in a range of advanced medical and surgical interventions, a mix of inpatient and outpatient services. It offers treatment facilities for various medical conditions under various specialties, which include allergy and immunology, blood (hematology), bones, muscles and joints (orthopedics), brain, spine and nervous system, cancer (oncology), circulatory (vascular), dermatology, digestive (gastroenterology), endocrine, diabetes and cardiology, infectious diseases, sleep apnea, kidneys stone treatment and failure (renal), lung (pulmonary), mouth, teeth and face (oral and maxillofacial), obstetrics and gynecology, psychiatry, arthritis and joint disease, surgery, and urology. It also offers treatment for irregular periods, vertigo, finger joint treatment, and piles. The Company's subsidiary includes Artemis Cardiac Care Private Limited.
Valuation and market data
| Last close | ₹344.90 |
|---|---|
| Market capitalisation | ₹5,453 crore |
| Enterprise value | ₹5,697 crore |
| P/E (TTM) | 52.58 |
| Price to book | 5.80 |
| Price to sales (TTM) | 2.82 |
| Book value per share | ₹59.50 |
| Dividend yield | 13.05% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Thu Jan 23 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹1,111 crore | ₹139 crore | ₹104 crore | 6.56 |
| Mar 2025 | ₹970 crore | ₹108 crore | ₹82 crore | 5.37 |
| Mar 2024 | ₹886 crore | ₹68 crore | ₹49 crore | 3.62 |
| Mar 2023 | ₹745 crore | ₹51 crore | ₹38 crore | 2.89 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 58.4% |
|---|---|
| Foreign institutions (FII) | 12.3% |
| Mutual funds | 1.3% |
| Other domestic institutions | 1.1% |
| Retail and others | 26.9% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.